2 results
10-Q
2024 Q1
ADCT
Adc Therapeutics SA
6 May 24
Quarterly report
6:38am
As of | As of | ||||||||||||
March 31, 2024 | December 31, 2023 | ||||||||||||
Exercise price in $ | 24.70 and 28.07 | 24.70 and 28.07 | |||||||||||
Share price in $ | 4.49 | 1.66 | Risk-free interest rate | 5.0 | % | 4.6 | % | ||||||
Expected volatility | 136.2 | % | 116.0 | % | |||||||||
Expected term (months) | 13.7 months | 16.7 months | |||||||||||
Dividend yield | — | — | Black-Scholes value in $ | 0.80 and 0.71 | 0.07 and 0.06 |
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
As of | As of | ||||||||||||
December 31, 2023 | December 31, 2022 | ||||||||||||
Exercise price in $ | 24.70 and 28.07 | 24.70 and 28.07 | |||||||||||
Share price in $ | 1.66 | 3.84 | Risk-free interest rate | 4.6 | % | 4.3 | % | ||||||
Expected volatility | 116 | % | 70 | % | |||||||||
Expected term (months) | 16.7 months | 28.7 months | |||||||||||
Dividend yield | — | — | Black-Scholes value in $ | 0.07 and 0.06 | 0.20 and 0.16 |
- Prev
- 1
- Next